Bill Mann explains why Eli Lilly and Adobe remain strong long-term buys

Name: Bill Mann explains why Eli Lilly and Adobe remain strong long-term buys
Uploaded: 2026-08-26T20:47:30Z
Duration: 3 min 18 s
Description: Host Liz Claman is joined by Motley Fool Asset Management Chief Investment Strategist Bill Mann to discuss Eli Lilly's market performance. Despite employers pulling back on coverage for weight-loss drugs like Zeppbound, Mann remains bullish on Eli Lilly's long-term growth and high profit margins. He also shares why Adobe is a strong value play in the tech sector due to its AI training advantages.

The Claman Countdown · FBN · Aired Wed, Aug 26 · 3m 18s

Watch Now

Already a subscriber?

Host Liz Claman is joined by Motley Fool Asset Management Chief Investment Strategist Bill Mann to discuss Eli Lilly's market performance. Despite employers pulling back on coverage for weight-loss drugs like Zeppbound, Mann remains bullish on Eli Lilly's long-term growth and high profit margins. He also shares why Adobe is a strong value play in the tech sector due to its AI training advantages.